HUM - Humana Inc Stock Price, Fair Value and News

320.50USD-0.48 (-0.15%)Market Closed

Market Summary

USD320.50-0.48

Market Closed

-0.15%

HUM Alerts

Big fall in earnings (Y/Y)

HUM Stock Price

View Fullscreen

HUM RSI Chart

HUM Valuation

Market Cap

38.6B

Price/Earnings (Trailing)

19.4

Price/Sales (Trailing)

0.35

EV/EBITDA

10.97

Price/Free Cashflow

-11.92

HUM Price/Sales (Trailing)

HUM Profitability

EBT Margin

2.55%

Return on Equity

12.3%

Return on Assets

3.97%

Free Cashflow Yield

-8.39%

HUM Fundamentals

HUM Revenue

Revenue (TTM)

109.2B

Rev. Growth (Yr)

10.73%

Rev. Growth (Qtr)

11.9%

HUM Earnings

Earnings (TTM)

2.0B

Earnings Growth (Yr)

-40.19%

Earnings Growth (Qtr)

236.97%

Breaking Down HUM Revenue

Last 7 days

4.8%

Last 30 days

4.0%

Last 90 days

-15.4%

Trailing 12 Months

-39.4%

How does HUM drawdown profile look like?

HUM Financial Health

Current Ratio

1.67

Debt/Equity

0.77

Debt/Cashflow

-0.18

HUM Investor Care

Dividend Yield

0.65%

Dividend/Share (TTM)

2.05

Buy Backs (1Y)

3.56%

Diluted EPS (TTM)

16.23

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	109.2B	0	0	0
2023	95.6B	98.7B	102.4B	106.4B
2022	86.4B	89.4B	91.5B	92.9B
2021	75.9B	77.5B	78.1B	83.1B
2020	67.7B	70.6B	74.4B	74.2B
2019	58.7B	60.7B	62.8B	64.9B
2018	54.3B	55.0B	55.9B	56.9B
2017	54.3B	53.9B	53.5B	53.8B
2016	54.3B	54.5B	54.9B	54.4B
2015	50.6B	52.1B	53.3B	54.3B
2014	42.5B	44.4B	46.4B	48.5B
2013	39.4B	40.0B	40.7B	41.3B
2012	37.9B	38.3B	38.6B	39.1B
2011	34.4B	35.1B	36.1B	36.8B
2010	31.5B	32.2B	32.9B	33.6B
2009	29.5B	29.9B	30.5B	30.7B
2008	0	26.4B	27.6B	28.8B
2007	0	0	0	25.3B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022

Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Humana Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Feb 22, 2024	ventura joseph c	acquired	-	-	3,411	chief legal officer
Feb 22, 2024	fleming william kevin	sold (taxes)	-448,845	366	-1,226	chief corporate aff. officer
Feb 22, 2024	huval timothy s.	acquired	-	-	3,712	chief administrative officer
Feb 22, 2024	renaudin george ii	sold (taxes)	-101,777	366	-278	president, medicare & medicaid
Feb 22, 2024	broussard bruce d	sold (taxes)	-3,102,010	366	-8,473	chief executive officer
Feb 22, 2024	agrawal vishal	acquired	-	-	3,010	chief strat & corp dev officer
Feb 22, 2024	broussard bruce d	acquired	-	-	22,572	chief executive officer
Feb 22, 2024	ventura joseph c	sold (taxes)	-422,119	366	-1,153	chief legal officer
Feb 22, 2024	renaudin george ii	acquired	-	-	1,104	president, medicare & medicaid
Feb 22, 2024	diamond susan m	sold (taxes)	-411,868	366	-1,125	chief financial officer

Which funds bought or sold HUM recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 02, 2024	New Jersey Better Educational Savings Trust	unchanged	-	-99,426	310,314	0.59%
May 02, 2024	TOBAM	added	38.97	1,468,000	29,451,000	2.64%
May 02, 2024	Graypoint LLC	reduced	-21.19	-146,352	216,777	0.02%
May 02, 2024	Supplemental Annuity Collective Trust of NJ	unchanged	-	-177,744	554,752	0.17%
May 02, 2024	Quent Capital, LLC	reduced	-45.16	-99,583	70,830	0.01%
May 02, 2024	NJ State Employees Deferred Compensation Plan	unchanged	-	-255,507	797,456	0.10%
May 02, 2024	NORDEA INVESTMENT MANAGEMENT AB	reduced	-1.47	-4,377,200	13,095,900	0.01%
May 02, 2024	AlphaQ Advisors LLC	reduced	-2.38	-85,102	241,317	0.14%
May 02, 2024	LGT Financial Advisors LLC	new	-	258,306	258,306	0.30%
May 02, 2024	WRIGHT INVESTORS SERVICE INC	reduced	-43.32	-281,673	211,846	0.05%

Are Funds Buying or Selling HUM?

Are funds buying HUM calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own HUM

No. of Funds

HUM Alerts

Big fall in earnings (Y/Y)

Unveiling Humana Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 16, 2024	price t rowe associates inc /md/	3.2%	3,903,291	SC 13G/A
Feb 14, 2024	price t rowe associates inc /md/	3.2%	3,903,291	SC 13G/A
Feb 13, 2024	vanguard group inc	9.07%	11,171,000	SC 13G/A
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Feb 08, 2024	wellington management group llp	4.36%	5,363,011	SC 13G/A
Feb 07, 2024	blackrock inc.	9.1%	11,248,135	SC 13G/A
Feb 14, 2023	price t rowe associates inc /md/	6.0%	7,623,150	SC 13G/A
Feb 09, 2023	fmr llc	-	0	SC 13G/A
Feb 09, 2023	vanguard group inc	8.97%	11,357,974	SC 13G/A
Feb 06, 2023	wellington management group llp	6.01%	7,611,181	SC 13G

Recent SEC filings of Humana Inc

View All Filings

Date Filed	Form Type	Document
Apr 24, 2024	10-Q	Quarterly Report
Apr 24, 2024	8-K	Current Report
Apr 19, 2024	8-K	Current Report
Apr 18, 2024	4	Insider Trading
Apr 01, 2024	4	Insider Trading
Apr 01, 2024	4	Insider Trading
Apr 01, 2024	4	Insider Trading
Apr 01, 2024	4	Insider Trading
Mar 14, 2024	PX14A6G	PX14A6G
Mar 13, 2024	8-K	Current Report

Peers (Alternatives to Humana Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	454.0B	371.6B	7.11%	1.06%	20.29	1.22	14.64%	11.24%
CI	97.0B	206.0B	-5.44%	40.10%	25.17	0.47	12.55%	-43.95%
HCA	80.6B	66.7B	-7.36%	10.85%	14.74	1.21	9.59%	-4.59%
CVS	70.2B	360.9B	-25.07%	-18.74%	9.58	0.19	9.07%	78.49%
CNC	39.9B	155.5B	2.42%	11.29%	14.6	0.26	6.34%	84.42%
DVA	11.8B	12.3B	-0.62%	54.17%	14.46	0.96	5.77%	58.74%
UHS	11.6B	14.3B	-3.48%	18.85%	16.19	0.81	6.59%	6.24%
MID-CAP
CHE	8.5B	2.3B	-11.39%	3.11%	30	3.71	5.96%	18.29%
ACHC	6.1B	3.0B	-12.79%	-3.18%	-542.9	2.05	10.92%	-104.06%
AMN	2.3B	3.8B	2.01%	-30.11%	10.69	0.59	-27.73%	-52.50%
AMEH	2.1B	1.4B	-11.02%	9.69%	34.19	1.5	21.19%	34.42%
SMALL-CAP
ADUS	1.6B	1.1B	-4.40%	21.46%	25.46	1.5	11.31%	35.83%
BKD	1.4B	3.0B	10.96%	93.54%	-7.5	0.47	6.74%	20.73%
BEAT	58.7M	-	6.70%	1.83%	-4.01	-	-	-12.94%
AMS	18.5M	21.3M	3.05%	8.96%	34.8	0.87	8.00%	-62.25%

Humana Inc News

Latest updates

Humana Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	11.9%	29,611	26,462	26,423	26,747	26,742	22,439	22,799	23,662	23,970	21,054	20,697	20,645	20,668	16,093	20,075	19,083	18,935	16,295	16,241	16,245	16,107
S&GA Expenses	-20.5%	3,042	3,827	3,271	3,111	2,979	3,551	3,061	3,173	2,886	3,395	2,603	2,116	2,007	3,068	2,513	2,354	2,117	2,129	1,889	1,703	1,660
EBITDA Margin	-14.0%	0.04*	0.04*	0.05*	0.05*	0.05*	0.05*	0.05*	0.06*	0.05*	0.05*	0.05*	0.05*	-	-	-	-	-	-	-	-	-
Interest Expenses	8.9%	159	146	114	120	113	108	102	101	90.00	91.00	88.00	79.00	68.00	72.00	75.00	76.00	60.00	58.00	62.00	60.00	62.00
Income Taxes	434.7%	251	-75.00	256	296	359	-58.00	107	427	286	-51.00	120	183	233	-178	450	783	252	79.00	200	301	183
Earnings Before Taxes	271.6%	1,014	-591	1,098	1,262	1,614	-71.00	1,297	1,122	1,220	-60.00	1,636	738	1,040	-458	1,755	2,586	717	593	888	1,229	746
EBT Margin	-19.9%	0.03*	0.03*	0.04*	0.04*	0.04*	0.04*	0.04*	0.04*	0.04*	0.04*	0.04*	0.04*	-	-	-	-	-	-	-	-	-
Net Income	237.0%	741	-541	832	959	1,239	-15.00	1,195	696	930	-14.00	1,531	588	828	-274	1,340	1,828	473	512	689	940	566
Net Income Margin	-22.1%	0.02*	0.02*	0.03*	0.03*	0.03*	0.03*	0.03*	0.04*	0.04*	0.04*	0.03*	0.03*	-	-	-	-	-	-	-	-	-
Free Cashflow	103.3%	246	-7,417	1,018	2,912	6,464	-5,402	8,165	680	7.00	-493	2,509	31.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	6.4%	50,091	47,065	55,905	56,455	54,776	43,055	50,765	46,820	46,308	44,358	45,320	38,070	37,415	34,969	38,477	38,455	34,633	29,074	29,180	28,913	28,349
Current Assets	9.4%	32,796	29,986	38,253	38,759	37,532	26,183	33,711	27,217	26,840	24,893	25,815	25,790	25,526	23,641	27,031	27,868	24,551	19,888	20,324	20,160	19,673
Cash Equivalents	25.9%	5,910	4,694	15,148	16,214	13,735	5,061	13,558	5,220	4,864	3,394	4,304	3,378	3,877	4,673	7,985	7,163	6,054	4,054	5,527	4,778	3,877
Net PPE	-1.7%	2,979	3,030	3,342	3,309	3,234	3,221	3,218	3,121	3,189	3,073	2,898	2,690	2,507	2,371	2,228	2,118	2,023	1,955	1,864	1,796	1,754
Goodwill	0.1%	9,563	9,550	9,540	9,539	9,320	9,142	9,096	8,911	11,139	11,092	10,806	4,914	4,602	4,447	4,443	4,443	4,443	3,928	3,922	3,922	3,897
Liabilities	10.3%	33,905	30,747	38,901	39,564	38,142	27,685	34,448	31,310	30,966	28,255	29,038	23,227	23,225	21,241	22,709	24,039	22,278	17,037	17,579	17,041	17,508
Current Liabilities	4.3%	19,689	18,872	27,823	28,279	26,942	17,178	25,051	17,839	17,532	15,331	15,027	15,051	15,300	13,394	14,905	16,455	14,830	10,929	11,106	11,539	11,927
Long Term Debt	21.3%	12,390	10,213	9,483	9,722	9,743	9,034	7,798	11,290	11,285	10,541	11,466	6,063	6,062	6,060	6,059	6,058	6,057	4,967	5,365	4,377	4,376
LT Debt, Non Current	-100.0%	-	10,213	9,483	9,722	9,743	9,034	7,798	11,290	11,285	10,541	11,466	6,063	6,062	6,060	6,059	6,058	6,057	4,967	5,365	4,377	4,376
Shareholder's Equity	-0.5%	16,186	16,262	16,949	16,891	16,634	15,311	16,317	15,510	15,342	16,103	16,282	14,843	14,190	13,728	15,768	14,416	12,355	12,037	11,601	11,872	10,841
Retained Earnings	2.3%	28,173	27,540	28,191	27,468	26,619	25,492	25,606	24,511	23,915	23,086	23,191	21,751	21,252	20,517	20,872	19,616	17,871	17,483	17,045	16,429	15,563
Additional Paid-In Capital	0.7%	3,369	3,346	3,362	3,313	3,262	3,246	3,234	3,153	3,103	3,082	3,064	3,018	2,712	2,705	2,940	2,898	2,857	2,820	2,608	2,763	2,722
Shares Outstanding	-	121	-	123	124	125	-	127	127	126	-	129	129	129	-	132	132	132	-	132	135	135
Minority Interest	0%	56.00	56.00	55.00	57.00	57.00	59.00	63.00	20.00	23.00	23.00	22.00	-	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	55,097	-	-	-	59,158	-	-	-	56,778	-	-	-	50,712	-	-	-	35,479	-

Cashflow (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Cashflow (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	105.9%	423	-7,134	1,252	3,176	6,687	-5,127	8,453	959	302	-96.00	2,835	360	-837	283	1,815	3,067	474	512	2,442	1,434	896
Share Based Compensation	36.4%	45.00	33.00	53.00	51.00	38.00	43.00	80.00	50.00	43.00	48.00	48.00	45.00	39.00	52.00	47.00	46.00	36.00	44.00	43.00	43.00	33.00
Cashflow From Investing	53.1%	-414	-882	-585	-733	-1,292	-1,012	1,676	-1,022	-648	-102	-4,251	-715	-1,488	-55.00	-148	-1,652	-1,210	-801	-566	-56.00	145
Cashflow From Financing	149.5%	1,207	-2,438	-1,733	36.00	3,279	-2,358	-1,791	419	1,816	-712	2,342	-144	1,529	-3,540	-845	-306	2,736	-1,184	-1,127	-477	493
Dividend Payments	-1.8%	109	111	109	111	100	101	100	100	91.00	91.00	90.00	90.00	83.00	84.00	83.00	83.00	73.00	75.00	74.00	74.00	68.00
Buy Backs	25.6%	717	571	379	529	94.00	1,064	4.00	4.00	1,024	43.00	3.00	3.00	30.00	1,790	5.00	8.00	17.00	60.00	1,000	-	10.00

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

HUM Income Statement

2024-03-31

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenue from Contract with Customer, Product and Service [Extensible Enumeration]	Health Care [Member]	Health Care [Member]
Revenues:
Premiums	$ 28,261	$ 25,550
Services	1,062	999
Investment income	288	193
Total revenues	29,611	26,742
Operating expenses:
Benefits	25,124	21,858
Operating costs	3,042	2,979
Depreciation and amortization	209	186
Total operating expenses	28,375	25,023
Income from operations	1,236	1,719
Interest expense	159	113
Other expense (income), net	63	(8)
Income (loss) before income taxes and equity in net losses	1,014	1,614
Provision for income taxes	251	359
Equity in net losses	(24)	(17)
Net income	739	1,238
Net loss attributable to noncontrolling interests	2	1
Net income attributable to Humana	$ 741	$ 1,239
Basic earnings per common share (in dollars per share)	$ 6.13	$ 9.91
Diluted earnings per common share (in dollars per share)	$ 6.11	$ 9.87

HUM Balance Sheet

2024-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 5,910	$ 4,694
Investment securities	16,697	16,626
Receivables, net of allowances of $85 in 2024 and $88 in 2023	3,925	2,035
Other current assets	6,264	6,631
Total current assets	32,796	29,986
Property and equipment, net	2,979	3,030
Long-term investment securities	380	382
Equity method investments	730	740
Goodwill	9,563	9,550
Other long-term assets	3,643	3,377
Total assets	50,091	47,065
Current liabilities:
Benefits payable	11,729	10,241
Trade accounts payable and accrued expenses	6,504	6,569
Book overdraft	333	353
Unearned revenues	301	266
Short-term debt	822	1,443
Total current liabilities	19,689	18,872
Long-term debt	12,390	10,213
Other long-term liabilities	1,826	1,662
Total liabilities	33,905	30,747
Commitments and Contingencies (Note 13)
Stockholders’ equity:
Preferred stock, $1 par; 10,000,000 shares authorized; none issued	0	0
Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,690,593 shares issued at March 31, 2024 and 198,690,082 shares issued at December 31, 2023	33	33
Capital in excess of par value	3,369	3,346
Retained earnings	28,173	27,540
Accumulated other comprehensive loss	(1,086)	(999)
Treasury stock, at cost, 78,189,958 shares at March 31, 2024 and 76,465,862 shares at December 31, 2023	(14,359)	(13,658)
Total stockholders' equity	16,130	16,262
Noncontrolling interests	56	56
Total equity	16,186	16,318
Total liabilities and equity	$ 50,091	$ 47,065

About Humana Inc

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of PBM business. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

CEO	Mr. Bruce Dale Broussard
WEBSITE	humana.com
INDUSTRY	Healthcare Plans
EMPLOYEES	65535

Humana Inc Frequently Asked Questions

What is the ticker symbol for Humana Inc? What does HUM stand for in stocks?

HUM is the stock ticker symbol of Humana Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Humana Inc (HUM)?

As of Fri May 03 2024, market cap of Humana Inc is 38.62 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of HUM stock?

You can check HUM's fair value in chart for subscribers.

What is the fair value of HUM stock?

You can check HUM's fair value in chart for subscribers. The fair value of Humana Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Humana Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for HUM so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Humana Inc a good stock to buy?

The fair value guage provides a quick view whether HUM is over valued or under valued. Whether Humana Inc is cheap or expensive depends on the assumptions which impact Humana Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HUM.

What is Humana Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 03 2024, HUM's PE ratio (Price to Earnings) is 19.4 and Price to Sales (PS) ratio is 0.35. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HUM PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Humana Inc's stock?

In the past 10 years, Humana Inc has provided 0.12 (multiply by 100 for percentage) rate of return.